Consistent with our previous results5, biweekly recombinant mouse IL-22 (rmIL-22) treatment in the high-fat diet-induced obesity murine model induced a reduction in body weight which was accompanied by improved glucose tolerance (Supplementary Fig. 1a–c). Here, IL22 is linked to obesity disorder.